Psychedelics

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.

Trend Stats

1-Month Return +15.76%
3-Month Return +20.61%
12-Month Return +86.87%
Volatility Score 3.4
RSI 64.6
ST Trend Up
LT Trend Up

Short-Term Trend

Up

The Short-Term Trend is a metric that gauges an ETF's short-term price trend.

Long-Term Trend

Up

The Long-Term Trend is a metric that gauges an ETF's long-term price trend.

Performance

Psychedelics
S&P 500 Index

Components

Symbol Company Market Cap 12 mo return Performance over the past 12 months 3 mo return Performance over the past 3 months 1 mo return Performance over the past month Vol Score Our gauge of the ETF's recent volatility ST Trend A metric that gauges an ETF's short-term price trend LT Trend A metric that gauges an ETF's long-term price trend
JNJ Johnson&Johnson $547B +49.58% +0.51% -6.94% 2.1 Down Up
ABBV AbbVie $365B +7.49% -6.59% -3.10% 2.8 Down Down
NBIX Neurocrine Biosc $13B +20.15% -3.15% -0.59% 3.0 Neutral Down
ALKS Alkermes $5.5B +5.03% -1.50% -4.76% 3.1 Up Up
SUPN Supernus Pharm $2.8B +45.71% -0.64% -6.98% 3.2 Down Neutral
DFTX DEFINIUM $2.4B +0.00% +28.55% +5.34% 6.1 Up Up
ATAI ATAI BECKLEY $1.5B +176.00% +10.11% +11.89% 7.9 Up Down
GHRS GH RSRCH $1.4B +81.83% +32.25% +40.69% 6.9 Up Up
CMPS COMPASS PATH SP ADR $1.2B +115.04% +34.68% +60.32% 7.7 Up Up
ANRO ALTO NEURO $874M +922.13% +61.11% +6.54% 7.7 Up Up
DRUG BRIGHT MINDS $851M +170.31% +11.85% +21.25% 5.1 Up Up
RLMD RELMADA THERAPEU $801M +1992.58% +115.21% +7.61% 5.7 Up Up
HELP CYBIN $257M +0.00% -22.21% +3.21% 8.0 Undefined Undefined
STIM NEURONETICS $141M -55.90% -3.35% +35.57% 8.3 Up Down
NRXP NRX PHARMA $102M +50.44% +47.14% +43.06% 6.4 Up Up
IXHL INCANNEX HEAL $64M +14.29% -51.01% +53.72% 7.5 Up Down
IGC IGC Pharma $33M +10.97% +24.04% +23.40% 6.7 Up Down
QNTM QUANTUM BIO-SB $32M -28.39% +21.18% +25.85% 10.9 Up Down
NEUP NEUPHORIA $28M +3.26% +29.85% +26.70% 4.3 Up Down
VTGN Vistagen Thera $25M -73.65% +12.11% +4.20% 6.7 Up Down
KTTA PASITHEA THERAP $21M -39.93% -2.32% +13.04% 7.4 Up Up
PBM PSYENCE BIO $14M -71.09% +56.10% +163.71% 29.2 Up Down
ENVB ENVERIC BIOSCIE $7.9M -74.22% +37.11% +86.45% 22.2 Up Down
CMND CLEARMIND MEDCN $6.7M -98.37% -69.68% -39.07% 30.3 Down Down
NUMIF Numinus Wellness $0 +18.48% -23.08% +150.00% 42.4 Up Down